Clinical Trial Update: A Study to Assess the Efficacy and Safety of Alefacept in Kidney Transplant Recipients [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of Alefacept in de novo kidney transplant recipients; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Alefacept (Alefacept)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: De Novo Kidney Transplantation | Phase 2 | Status: COMPLETED | Results posted: 2016-02-04